257 related articles for article (PubMed ID: 37496132)
1. An Insight on Skin Cancer About Different Targets With Update on Clinical Trials and Investigational Drugs.
Vishwas S; Paul SD; Singh D
Curr Drug Deliv; 2024; 21(6):852-869. PubMed ID: 37496132
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs.
Harwansh RK; Deshmukh R
Crit Rev Oncol Hematol; 2020 Oct; 154():103070. PubMed ID: 32871325
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy for thyroid cancer: An updated review of investigational agents.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
[TBL] [Abstract][Full Text] [Related]
5. [New therapies for skin cancers].
Basset-Seguin N; Herms F
Ann Dermatol Venereol; 2020 Apr; 147(4):255-257. PubMed ID: 32087982
[No Abstract] [Full Text] [Related]
6. Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.
Ugurel S; Röhmel J; Ascierto PA; Flaherty KT; Grob JJ; Hauschild A; Larkin J; Long GV; Lorigan P; McArthur GA; Ribas A; Robert C; Schadendorf D; Garbe C
Eur J Cancer; 2017 Sep; 83():247-257. PubMed ID: 28756137
[TBL] [Abstract][Full Text] [Related]
7. Clinical advances in targeting epigenetics for cancer therapy.
Feng S; De Carvalho DD
FEBS J; 2022 Mar; 289(5):1214-1239. PubMed ID: 33545740
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in melanoma.
Griewank KG
Scand J Clin Lab Invest Suppl; 2016; 245():S104-12. PubMed ID: 27467728
[TBL] [Abstract][Full Text] [Related]
9. Investigational new drugs for brain cancer.
Staedtke V; Bai RY; Laterra J
Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
[TBL] [Abstract][Full Text] [Related]
10. Investigational drugs for head and neck cancer.
Bossi P; Alfieri S
Expert Opin Investig Drugs; 2016 Jul; 25(7):797-810. PubMed ID: 27054910
[TBL] [Abstract][Full Text] [Related]
11. Investigational drugs for treating anal cancer and future perspectives.
Bustamante L; Frakes J; Hoffe S; Kim R
Expert Opin Investig Drugs; 2016; 25(1):51-62. PubMed ID: 26560877
[TBL] [Abstract][Full Text] [Related]
12. Investigational drugs for nasopharyngeal carcinoma.
Ma BBY; Hui EP; Chan ATC
Expert Opin Investig Drugs; 2017 Jun; 26(6):677-685. PubMed ID: 28446055
[TBL] [Abstract][Full Text] [Related]
13. Treatment for metastatic malignant melanoma: old drugs and new strategies.
Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
[TBL] [Abstract][Full Text] [Related]
14. Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients.
Rogiers A; van den Oord JJ; Garmyn M; Stas M; Kenis C; Wildiers H; Marine JC; Wolter P
Drugs Aging; 2015 Oct; 32(10):821-34. PubMed ID: 26442859
[TBL] [Abstract][Full Text] [Related]
15. Investigational drugs for the treatment of cervical cancer.
Barra F; Lorusso D; Leone Roberti Maggiore U; Ditto A; Bogani G; Raspagliesi F; Ferrero S
Expert Opin Investig Drugs; 2017 Apr; 26(4):389-402. PubMed ID: 28274154
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.
Chan KK; Glenny AM; Weldon JC; Furness S; Worthington HV; Wakeford H
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010341. PubMed ID: 26625332
[TBL] [Abstract][Full Text] [Related]
17. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on investigational drugs and immunotherapies for glioblastoma.
Miller JJ; Curry WT; Cahill DP; Dietrich J
Expert Opin Investig Drugs; 2016 Sep; 25(9):1007-9. PubMed ID: 27415034
[No Abstract] [Full Text] [Related]
19. Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.
Guazzelli A; Bakker E; Tian K; Demonacos C; Krstic-Demonacos M; Mutti L
Expert Opin Investig Drugs; 2017 Aug; 26(8):933-944. PubMed ID: 28679291
[TBL] [Abstract][Full Text] [Related]
20. The Systemic Management of Advanced Melanoma in 2016.
Heppt MV; Dietrich C; Graf SA; Ruzicka T; Tietze JK; Berking C
Oncol Res Treat; 2016; 39(10):635-642. PubMed ID: 27710977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
